For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

According to the company, the system exhibited “durable” clinical results and “strong” valve ... with severe aortic stenosis who underwent treatment with either the Evolut TAVR or surgery ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Furthermore, the study assessed the performance of the valve and procedural outcomes ... "Medtronic reports outcomes from aortic stenosis treatment study of TAVR system" was originally created ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR ... to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael ...